Marshall Wace North America Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$141M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$127M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$109M |
| 4 |
Merck
MRK
|
+$97.7M |
| 5 |
Zimmer Biomet
ZBH
|
+$80.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$174M |
| 2 |
Intel
INTC
|
+$133M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$130M |
| 4 |
AbbVie
ABBV
|
+$122M |
| 5 |
NextEra Energy
NEE
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.77% |
| 2 | Technology | 17.59% |
| 3 | Consumer Discretionary | 13.24% |
| 4 | Industrials | 9.9% |
| 5 | Financials | 8.04% |
Similar funds
Marshall Wace North America's Q3 2020 Portfolio in Review
As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.
- Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
- Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
- Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
- Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
- Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
- Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
- Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.
Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.